reduction in antifungal therapy.
reduction in median length of stay in the ICU.
sooner than blood culture.
pharmacy costs per patient.
Identified escalation and de-escalation opportunities in patients tested with T2Candida.
of patients who tested positive received appropriate therapy in <9 hours
Not visiting from the US or Europe?
T2Direct Diagnostics™ may be available in your area.
Please contact firstname.lastname@example.org for more detailed information about availability in your area.
Continue to the EU page